Cargando…
[Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6–11) (antagonist G) inducesP-1 transcription and sensitizes cells to chemotherapy
[Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6–11) (antagonist G) inhibits small cell lung cancer (SCLC) growth and is entering Phase II clinical investigation for the treatment of SCLC. As well as acting as a neuropeptide receptor antagonist, antagonist G stimulates c-jun-N-terminal kinase (JNK)...
Autores principales: | MacKinnon, A C, Waters, C, Rahman, I, Harani, N, Rintoul, R, Haslett, C, Sethi, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374683/ https://www.ncbi.nlm.nih.gov/pubmed/10970698 http://dx.doi.org/10.1054/bjoc.2000.1362 |
Ejemplares similares
-
[Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6–11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism
por: MacKinnon, A C, et al.
Publicado: (1999) -
Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6–11)-induced growth inhibition
por: Waters, C M, et al.
Publicado: (2003) -
Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.
por: Jones, D. A., et al.
Publicado: (1996) -
In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth.
por: Everard, M. J., et al.
Publicado: (1992) -
Functional analysis of the p.[Arg74Trp;Val201Met;Asp1270Asn]/p.Phe508del CFTR mutation genotype in human native colon
por: Schucht, Sylvia, et al.
Publicado: (2019)